Related Experiment Video
Updated: Jan 4, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Pneumocystis pneumonia in a treatment-naive rheumatoid arthritis patient
Anuoluwapo Shobayo1, Chiemeziem Nwanyanwu1, Edward Chapnick1
1The Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Abstract:
A HIV-negative, newly diagnosed patient with rheumatoid arthritis (RA) was found to have pneumocystis jiroveci pneumonia. The infection was treated with three weeks of atovaquone and corticosteroids. Clinicians should be aware of pneumocystis pneumonia as an infection in RA patients not receiving treatment.
Insights
Newly diagnosed rheumatoid arthritis patients can develop pneumocystis pneumonia, even without HIV. Early recognition and treatment are crucial for managing this opportunistic infection in rheumatoid arthritis (RA) patients.
Area of Science:
- Rheumatology
- Infectious Diseases
- Pulmonology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting joints.
- Patients with RA may be immunocompromised due to the disease itself or its treatments.
- Opportunistic infections are a known complication in immunocompromised individuals.
Observation:
- A case study of a human immunodeficiency virus (HIV)-negative patient newly diagnosed with RA.
- The patient presented with symptoms indicative of an infection.
- Diagnostic tests confirmed the presence of *Pneumocystis jiroveci* pneumonia (PCP).
Findings:
- The patient, despite being HIV-negative, developed PCP, a serious opportunistic infection.
- Treatment involved a three-week course of atovaquone and corticosteroids.
- The patient's RA was newly diagnosed and not yet undergoing immunosuppressive therapy.
Implications:
- This case highlights that RA patients, irrespective of HIV status, are at risk for PCP.
- Clinicians must maintain a high index of suspicion for PCP in RA patients, even those not on immunosuppressive treatment.
- Awareness of PCP as a potential complication in RA management is essential for timely diagnosis and intervention.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology